The University of Chicago Header Logo

Connection

Junko Matsuzaki to gp100 Melanoma Antigen

This is a "connection" page, showing publications Junko Matsuzaki has written about gp100 Melanoma Antigen.
Connection Strength

0.054
  1. Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients. Melanoma Res. 2022 04 01; 32(2):88-97.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.